✦ LIBER ✦

Population pharmacokinetic modelling ofS-warfarin to evaluate the design of drug–drug interaction studies for CYP2C9

✍ Scribed by Kerenaftali Klein; Ivelina Gueorguieva; Leon Aarons

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

OC036—Impact Of Cyp2c9 Polymorphisms On

✍ Rollason, V.; Gschwind, L.; Boehlen, F.; Rebsamen, M.; Combescure, C.; Grünenwal 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Warfarin metabolism and anticoagulant ef

✍ Mordechai Muszkat; Simcha Blotnik; Amir Elami; Irena Krasilnikov; Yoseph Caraco 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 811 KB

Pharmacokinetic-pharmacodynamic modellin

✍ H. G. Schaefer; R. Heinig; G. Ahr; H. Adelmann; W. Tetzloff; J. Kuhlmann 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 318 KB

The use of mechanistic DM-PK-PD modellin

✍ Gemma L. Dickinson; Martin S. Lennard; Geoffrey T. Tucker; Amin Rostami-Hodjegan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

Eltrombopag, an oral thrombopoietin rece

✍ Julian Jenkins; Daphne Williams; Yanli Deng; David A. Collins; Valerie S. Kitche 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 301 KB

The design of pharmacokinetic studies to

✍ Brian Law; Dave Temesi 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 442 KB